Nonetheless, recombinant human p53 adenovirus vectors (such as Ad5RSV-p53 and AdCMV-p53) have been used to replace mutated TP53 with wild-type gene in order to restore p53 functionality, with potential utility as a new treatment approach for head and neck cancers [110,111,112]. Here, TP53 is linked to head and neck cancer.